Fineberg, HV. Pandemic preparedness and response – lessons from the H1N1 influenza of 2009. New England Journal of Medicine
2014; 370: 1335–1342.
Ginsberg, J, et al.
Detecting influenza epidemics using search engine query data. Nature
2009; 457: 1012–1014.
Zhang, YH, et al.
Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nature Communications
2013; 4: 1418.
Wang, Z, et al.
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proceedings of the National Academy of Sciences USA
2014; 111: 769–774.
Horby, P, et al.
An updated systematic review of the role of host genetics in susceptibility to influenza. Influenza and Other Respiratory Viruses
2013; 7 (Suppl. 2): 37–41.
Horby, P, et al.
The role of host genetics in susceptibility to influenza: a systematic review. PLoS ONE
2012; 7: e33180.
Horby, P, et al.
What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1?
Epidemiology and Infection
2010; 138: 1550–1558.
Brass, AL, et al.
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell
2009; 139: 1243–1254.
Jia, R, et al.
The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. Journal of Virology
2012; 86: 13697–13707.
Everitt, AR, et al.
IFITM3 restricts the morbidity and mortality associated with influenza. Nature
2012; 484: 519–523.
Mills, TC, et al.
IFITM3 and susceptibility to respiratory viral infections in the community. Journal of Infectious Diseases
2014; 209: 1028–1031.
Moher, D, et al.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. British Medical Journal
2009; 339: b2535.
Higgins, JP, et al.
Measuring inconsistency in meta-analyses. British Medical Journal
2003; 327: 557–560.
Jackson, D, White, IR, Riley, RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Statistics in Medicine
2012; 31: 3805–3820.
DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Controlled Clinical Trials
1986; 7: 177–188.
Egger, M, et al.
Bias in meta-analysis detected by a simple, graphical test. British Medical Journal
1997; 315: 629–634.
Peters, JL, et al.
Comparison of two methods to detect publication bias in meta-analysis. Journal of the American Medical Association
2006; 295: 676–680.
Gao, HN, et al.
Clinical findings in 111 cases of influenza A (H7N9) virus infection. New England Journal of Medicine
2013; 368: 2277–2285.
Bautista, E, et al.
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. New England Journal of Medicine
2010; 362: 1708–1719.
Husain, M. Avian influenza A (H7N9) virus infection in humans: Epidemiology, evolution, and pathogenesis. Journal of Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases
2014; 28c: 304–312.
Gao, R, et al.
Human infection with a novel avian-origin influenza A (H7N9) virus. New England Journal of Medicine
2013; 368: 1888–1897.
Wang, D, et al.
Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Eurosurveillance
2014; 19: 33–49.
Dortmans, JC, et al.
Adaptation of novel H7N9 influenza A virus to human receptors. Scientific Reports
2013; 3: 3058.
Bowles, NE, et al.
Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions. Molecular Genetics & Genomic Medicine
2014; 2: 356–361.